Panel: "Can Self-Regulation Survive Scrutiny?"

Related content

• Research output

• IPR Policy Brief: Protecting patients and the NHS through full transparency in industry-NHS collaborations

  Research output: Book/Report › Commissioned report

• Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation

  Research output: Contribution to journal › Article › peer-review

• Activities

• AUTH/3876/2/24 - Complainants v Novo Nordisk Allegations about disclosure of transfers of value

  Activity: Knowledge Exchange (Industry, Government, NGOs) › Giving evidence or preparing policy briefs

• Projects

• Political economy of the UK pharmaceutical industry in an age of uncertainty and volatility

  Project: Research council